Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Zevra Therapeutics, Inc. (ZVRA) had Debt to Capital Ratio of 0.60 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$23.61M |
|
$-105.51M |
|
$7.42M |
|
$16.20M |
|
$110.61M |
|
$-87.00M |
|
$-3.14M |
|
$-90.14M |
|
$-90.14M |
|
$-105.51M |
|
$-105.51M |
|
$-105.51M |
|
$-105.51M |
|
$-87.00M |
|
$-81.50M |
|
46.25M |
|
46.25M |
|
$-2.28 |
|
$-2.28 |
|
| Balance Sheet Financials | |
$86.03M |
|
$0.36M |
|
$92.10M |
|
$178.13M |
|
$34.06M |
|
$59.50M |
|
$104.40M |
|
$138.46M |
|
$39.67M |
|
$-34.03M |
|
$39.67M |
|
53.67M |
|
| Cash Flow Statement Financials | |
$-69.67M |
|
$-22.16M |
|
$82.11M |
|
$43.05M |
|
$33.78M |
|
$-9.26M |
|
$15.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.60 |
1.50 |
|
68.59% |
|
-368.47% |
|
-368.47% |
|
-345.18% |
|
-381.75% |
|
-446.85% |
|
$-69.67M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
3.77 |
|
2.25 |
|
162.45 |
|
-266.00% |
|
310.07% |
|
-59.23% |
|
-106.39% |
|
$0.74 |
|
$-1.51 |
|
$-1.51 |
|